Guided Therapeutics Inc (GTHP.OB)

GTHP.OB on OTC BB

0.36USD
3:53pm EDT
Price Change (% chg)

$-0.01 (-4.00%)
Prev Close
$0.38
Open
$0.37
Day's High
$0.37
Day's Low
$0.33
Volume
34,000
Avg. Vol
107,649
52-wk High
$0.68
52-wk Low
$0.28

GTHP.OB

Chart for GTHP.OB

About

Guided Therapeutics, Inc. is a medical technology company focused on developing medical devices. The Company’s primary focus is the development of its LuViva non-invasive cervical cancer detection device and extension of its cancer detection technology into other cancers, especially esophageal. Its technology, including products... (more)
No analyst recommendations are available for GTHP.OB.

Overall

Beta: 0.70
Market Cap (Mil.): $28.31
Shares Outstanding (Mil.): 75.50
Dividend: --
Yield (%): --

Financials

  GTHP.OB Industry Sector
P/E (TTM): -- 43.73 33.70
EPS (TTM): -0.14 -- --
ROI: -360.59 6.73 17.35
ROE: -- 10.92 18.21
Search Stocks

Competitors

  Price Change
Merck & Co., Inc. (MRK.N) $60.58 +0.09
GlaxoSmithKline plc (GSK.L) 1,443.50p -5.50
Hologic, Inc. (HOLX.OQ) $24.79 +0.65
Qiagen NV (QGEN.DE) €17.77 -0.14
SpectraScience Inc (SCIE.PK) $0.03 -0.00

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Plunkett Research, Ltd.
$99.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks